We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 453 results
  1. Longitudinal investigation of brain activation during motor tasks in Friedreich ataxia: 24-month data from IMAGE-FRDA

    Friedreich ataxia (FRDA) is a progressive autosomal recessive disease. While motor dysfunction is the primary neurological hallmark, little is known...

    Rosita Shishegar, Ian H. Harding, ... Nellie Georgiou-Karistianis in Brain Structure and Function
    Article 23 October 2021
  2. An RNA-seq study in Friedreich ataxia patients identified hsa-miR-148a-3p as a putative prognostic biomarker of the disease

    Friedreich ataxia (FRDA) is a life-threatening hereditary ataxia; its incidence is 1:50,000 individuals in the Caucasian population. A unique...

    Chiara Vancheri, Andrea Quatrana, ... Francesca Amati in Human Genomics
    Article Open access 22 May 2024
  3. The Role of Verbal Fluency in the Cerebellar Cognitive Affective Syndrome Scale in Friedreich Ataxia

    Cerebellar pathology engenders the disturbance of movement that characterizes Friedreich ataxia (FRDA), yet the impact of cerebellar pathology on...

    Louise A. Corben, Eliza Blomfield, ... Adam P. Vogel in The Cerebellum
    Article Open access 20 April 2024
  4. Therapeutic Use of Interferon Gamma in Friedreich Ataxia

    Friedreich’s ataxia (FRDA) is a progressive neurodegenerative disorder caused by GAA triplet expansion in the FXN gene. At the cellular level, FRDA...
    Andrea Martinuzzi, Gabriella Paparella, ... Roberto Testi in Trials for Cerebellar Ataxias
    Chapter 2023
  5. Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application

    Friedreich ataxia (FRDA) is a rare genetic multisystem disorder caused by a pathological GAA trinucleotide repeat expansion in the FXN gene. The...

    Saumya Maheshwari, Gabriela Vilema-Enríquez, Richard Wade-Martins in Translational Neurodegeneration
    Article Open access 20 September 2023
  6. Prevalence and Diagnostic Journey of Friedreich’s Ataxia in the State of São Paulo, Brazil

    Friedreich's Ataxia (FRDA) is the leading cause of ataxia worldwide, but data on epidemiology and diagnostic journey are scarce, particularly in...

    Daiana Suelen Machado, Celiana Figueiredo Viana, ... Marcondes Cavalcante França Jr in The Cerebellum
    Article 23 March 2024
  7. Longitudinal Increases in Cerebral Brain Activation During Working Memory Performance in Friedreich Ataxia: 24-Month Data from IMAGE-FRDA

    Friedreich ataxia (FRDA) has been associated with functional abnormalities in cerebral and cerebellar networks, particularly in the ventral attention...

    Rosita Shishegar, Ian H. Harding, ... Nellie Georgiou-Karistianis in The Cerebellum
    Article 02 January 2020
  8. The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients

    Friedreich’s ataxia (FRDA) is the most common inherited recessive ataxia. Cardiomyopathy (CM) with myocardial hypertrophy is the predominant cause of...

    Chiara Pane, Assunta Trinchillo, ... Cinzia Valeria Russo in The Cerebellum
    Article 06 September 2022
  9. State of the Art and History of Therapeutics in Ataxias

    Research into novel therapeutics suggests that treatment of cerebellar ataxia may be attainable in the future. Recently, omaveloxolone, an NRF2...
    Chase Kingsbury, Shaila Ghanekar, ... Theresa A. Zesiewicz in Trials for Cerebellar Ataxias
    Chapter 2023
  10. Quantitative Oculomotor Assessment in Hereditary Ataxia: Discriminatory Power, Correlation with Severity Measures, and Recommended Parameters for Specific Genotypes

    Characterizing bedside oculomotor deficits is a critical factor in defining the clinical presentation of hereditary ataxias. Quantitative assessments...

    Pilar Garces, Chrystalina A. Antoniades, ... Alexander A. Tarnutzer in The Cerebellum
    Article Open access 14 January 2023
  11. Therapeutic Biomarkers in Friedreich’s Ataxia: a Systematic Review and Meta-analysis

    Although a large array of biomarkers have been investigated in Friedreich’s ataxia (FRDA) trials, the optimal biomarker for assessing disease...

    Maria Gavriilaki, Evangelia Chatzikyriakou, ... Vasilios K. Kimiskidis in The Cerebellum
    Article Open access 27 October 2023
  12. Removal of the GAA repeat in the heart of a Friedreich’s ataxia mouse model using CjCas9

    Most Friedreich ataxia (FRDA) cases are caused by the elongation of the GAA repeat (GAAr) sequence in the first intron of the FXN gene, leading to a...

    Pouiré Yaméogo, Catherine Gérard, ... Jacques P. Tremblay in Gene Therapy
    Article 14 February 2023
  13. Novel intragenic deletion within the FXN gene in a patient with typical phenotype of Friedreich ataxia: may be more prevalent than we think?

    Background

    Friedreich ataxia is the most common inherited ataxia in Europe and is mainly caused by biallelic pathogenic expansions of the GAA...

    Cinthia Aguilera, Anna Esteve-Garcia, ... Ariadna Padró-Miquel in BMC Medical Genomics
    Article Open access 01 December 2023
  14. The Responsiveness of Gait and Balance Outcomes to Disease Progression in Friedreich Ataxia

    To identify gait and balance measures that are responsive to change during the timeline of a clinical trial in Friedreich ataxia (FRDA), we...

    Sarah C. Milne, Seok Hun Kim, ... Louise A. Corben in The Cerebellum
    Article 02 December 2021
  15. Auditory Phenotypic Variability in Friedreich’s Ataxia Patients

    Auditory neural impairment is a key clinical feature of Friedreich’s Ataxia (FRDA). We aimed to characterize the phenotypical spectrum of the...

    Nehzat Koohi, Gilbert Thomas-Black, ... Doris-Eva Bamiou in The Cerebellum
    Article Open access 18 February 2021
  16. The Cost of Living with Inherited Ataxia in Ireland

    Inherited ataxias are a heterogenous group of neurodegenerative disorders characterised by progressive impairment of balance and coordination,...

    Mark J. Kelly, Petya Bogdanova-Mihaylova, ... Sinéad M. Murphy in The Cerebellum
    Article Open access 06 July 2021
  17. Autosomal and X-Linked Degenerative Ataxias: From Genetics to Promising Therapeutics

    Autosomal recessive cerebellar ataxias (ARCAs) refer to a large group of neurodegenerative disorders mainly affecting the cerebellum and the nervous...
    Anya Hadji, Aurélie Louit, ... Nicolas Dupré in Trials for Cerebellar Ataxias
    Chapter 2023
  18. Health-Related Quality of Life in Patients with Inherited Ataxia in Ireland

    Inherited cerebellar ataxias (CA) are heterogeneous progressive neurological conditions associated with significant functional limitations. This...

    Poornima Jayadev Menon, Tan **n Yi, ... Petya Bogdanova-Mihaylova in The Cerebellum
    Article 27 November 2023
  19. A Milestone in the Treatment of Ataxias: Approval of Omaveloxolone for Friedreich Ataxia

    The exciting news about the US FDA approval of omaveloxolone as the first-ever drug to be approved for an inherited ataxia is welcome news for...

    S. H. Subramony, D. L. Lynch in The Cerebellum
    Article 23 May 2023
  20. Compound heterozygosity for an expanded (GAA) and a (GAAGGA) repeat at FXN locus: from a diagnostic pitfall to potential clues to the pathogenesis of Friedreich ataxia

    Friedreich’s ataxia (FRDA) is usually due to a homozygous GAA expansion in intron 1 of the frataxin ( FXN ) gene. Rarely, uncommon molecular...

    Massimo Santoro, Alessia Perna, ... Gabriella Silvestri in neurogenetics
    Article 07 July 2020
Did you find what you were looking for? Share feedback.